Rigel Pharmaceuticals (RIGL)
NASDAQ:RIGL
Want to see RIGL full AI Analyst Report?
Rigel (RIGL) Ownership Overview
3.07% Insiders
28.65% Mutual Funds
<0.01% Other Institutional Investors
22.26% ETFs
46.02% Public Companies and Individual Investors
The ownership structure of Rigel (RIGL) stock is a mix of institutional, retail, and individual investors. Approximately 50.91% of the company’s stock is owned by Institutional Investors, 3.07% is owned by Insiders, and 46.02% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 24, 2026 | xxxxxxxxxxxxx | $145440 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $898016 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $2141500 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $2248575 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,501,578 | Institution | 13.54% | 80,200,591 | |
| 898,033 | Institution | 4.86% | 28,790,938 | |
| 833,138 | Institution | 4.51% | 26,710,404 | |
| 811,488 | Institution | 4.39% | 26,016,305 | |
| 731,849 | Institution | 3.96% | 23,463,079 | |
| 531,827 | Institution | 2.88% | 17,050,374 | |
| 480,000 | Institution | 2.60% | 15,388,800 | |
| 282,017 | Insider | 1.53% | 9,041,465 | |
| 186,059 | Institution | 1.01% | 5,965,052 | |
| 176,854 | Institution | 0.96% | 5,669,939 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,501,578 | Institution | 13.54% | 80,200,591 | |
| 731,849 | Institution | 3.96% | 23,463,079 | |
| 480,000 | Institution | 2.60% | 15,388,800 | |
| 186,059 | Institution | 1.01% | 5,965,052 | |
| 176,854 | Institution | 0.96% | 5,669,939 | |
| 152,536 | Institution | 0.83% | 4,890,304 | |
| 123,558 | Institution | 0.67% | 3,961,269 | |
| 103,093 | Institution | 0.56% | 3,305,162 | |
| 91,814 | Institution | 0.50% | 2,943,557 | |
| 81,276 | Institution | 0.44% | 2,605,709 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 782,952 | Institution | 4.24% | 24,576,863 | |
| 542,046 | Institution | 2.93% | 14,656,924 | |
| 473,489 | Institution | 2.56% | 14,190,465 | |
| 423,399 | Institution | 2.29% | 13,574,172 | |
| 204,484 | Institution | 1.11% | 5,529,247 | |
| 142,603 | Institution | 0.77% | 4,571,852 | |
| 131,439 | Institution | 0.71% | 4,213,934 | |
| 114,149 | Institution | 0.62% | 3,583,137 | |
| 97,175 | Institution | 0.53% | 3,050,323 | |
| 88,017 | Institution | 0.48% | 2,379,980 |
FAQ
Who Owns Rigel Pharmaceuticals (RIGL)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 3.07% is held by insiders, and 46.02% is held by retail investors.
What percentage of Rigel Pharmaceuticals (RIGL) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Rigel Pharmaceuticals (RIGL) stock is held by institutional investors.
What percentage of Rigel Pharmaceuticals (RIGL) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.02% of Rigel Pharmaceuticals (RIGL) stock is held by retail investors.
Who owns the most shares of Rigel Pharmaceuticals (RIGL)?
TIAA-CREF Funds owns the most shares of Rigel Pharmaceuticals (RIGL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.